Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duffy

Showing results (81-90 of 1,315) with videos related to

Pageof 132
Sort By:
Clinical Chemistry|July 27, 2002
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studiesMichael J Duffy
Clinical Biochemistry|August 28, 2001
Biochemical markers in breast cancer: which ones are clinically useful?M J Duffy
Neurology|June 15, 2011
The consequences of optic neuritis: more than meets the eyeCharles J Duffy
Health Law Vigil|May 29, 1986
Court of Appeals holds district court had no jurisdiction to award prospective reliefE J Duffy
Health Law Vigil|August 19, 1986
PRRB has jurisdiction to hear self-disallowed costs appealE J Duffy
Health Law Vigil|September 2, 1986
Home health agency can represent beneficiaries on appealE J Duffy
Health Law Vigil|September 16, 1986
Court vacates remand order in labor/delivery room caseE J Duffy
Health Law Vigil|April 3, 1987
7th Circuit orders recalculation of malpractice reimbursement under the 1986 ruleE J Duffy
Clinical Chemistry|October 1, 1995
Can molecular markers now be used for early diagnosis of malignancy?M J Duffy
Advances in Clinical Chemistry|January 1, 1996
The biochemistry of metastasisM J Duffy
Pageof 132

Showing results (81-90 of 1,315) with videos related to

Sort By:
Pageof 132
Clinical Chemistry|July 27, 2002
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studiesMichael J Duffy
Clinical Biochemistry|August 28, 2001
Biochemical markers in breast cancer: which ones are clinically useful?M J Duffy
Neurology|June 15, 2011
The consequences of optic neuritis: more than meets the eyeCharles J Duffy
Health Law Vigil|May 29, 1986
Court of Appeals holds district court had no jurisdiction to award prospective reliefE J Duffy
Health Law Vigil|August 19, 1986
PRRB has jurisdiction to hear self-disallowed costs appealE J Duffy
Health Law Vigil|September 2, 1986
Home health agency can represent beneficiaries on appealE J Duffy
Health Law Vigil|September 16, 1986
Court vacates remand order in labor/delivery room caseE J Duffy
Health Law Vigil|April 3, 1987
7th Circuit orders recalculation of malpractice reimbursement under the 1986 ruleE J Duffy
Clinical Chemistry|October 1, 1995
Can molecular markers now be used for early diagnosis of malignancy?M J Duffy
Advances in Clinical Chemistry|January 1, 1996
The biochemistry of metastasisM J Duffy
Pageof 132